ARTICLE | Clinical News
IGI Inc. regulatory update
September 13, 1993 7:00 AM UTC
IGI received three U.S. Patents covering its Novasome and Ultrasponge technologies. Patent No. 5,234,915 covers IGI's biodegradable gel-like complex, which is used as a non-irritating prolonged releas...